![These highlights do not include all the information needed to use TESTOSTERONE GEL safely and effectively. See full prescribing information for TESTOSTERONE GEL . TESTOSTERONE gel 1.62% for topical use CIII Initial These highlights do not include all the information needed to use TESTOSTERONE GEL safely and effectively. See full prescribing information for TESTOSTERONE GEL . TESTOSTERONE gel 1.62% for topical use CIII Initial](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-3.jpg&id=546325)
These highlights do not include all the information needed to use TESTOSTERONE GEL safely and effectively. See full prescribing information for TESTOSTERONE GEL . TESTOSTERONE gel 1.62% for topical use CIII Initial
Dissecting the importance of sex steroids balance for metabolic and reproductive health in men with Klinefelter syndrome: a rand
![Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis - The Lancet Healthy Longevity Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis - The Lancet Healthy Longevity](https://www.thelancet.com/cms/attachment/e24c9982-a714-49bb-bd8b-0da11eab5cc9/gr2_lrg.jpg)
Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis - The Lancet Healthy Longevity
![These highlights do not include all the information needed to use TESTOSTERONE GEL safely and effectively. See full prescribing information for TESTOSTERONE GEL . TESTOSTERONE gel 1.62% for topical use CIII Initial These highlights do not include all the information needed to use TESTOSTERONE GEL safely and effectively. See full prescribing information for TESTOSTERONE GEL . TESTOSTERONE gel 1.62% for topical use CIII Initial](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-8.jpg&id=546325)
These highlights do not include all the information needed to use TESTOSTERONE GEL safely and effectively. See full prescribing information for TESTOSTERONE GEL . TESTOSTERONE gel 1.62% for topical use CIII Initial
![FTC Sues to Stop Unlawful Blocking of Generic Androgel - IPWatchdog.com | Patents & Intellectual Property Law FTC Sues to Stop Unlawful Blocking of Generic Androgel - IPWatchdog.com | Patents & Intellectual Property Law](http://dailymed.nlm.nih.gov/dailymed/archives/image.cfm?archiveid=69226&type=img&name=carton-androgel-1percent-5g-30ct.jpg)
FTC Sues to Stop Unlawful Blocking of Generic Androgel - IPWatchdog.com | Patents & Intellectual Property Law
![Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis - The Lancet Healthy Longevity Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis - The Lancet Healthy Longevity](https://www.thelancet.com/cms/attachment/6f96bfc9-02a8-4311-8ff7-eff6b1978780/gr1.gif)
Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis - The Lancet Healthy Longevity
![These highlights do not include all the information needed to use TESTOSTERONE GEL safely and effectively. See full prescribing information for TESTOSTERONE GEL . TESTOSTERONE gel 1.62% for topical use CIII Initial These highlights do not include all the information needed to use TESTOSTERONE GEL safely and effectively. See full prescribing information for TESTOSTERONE GEL . TESTOSTERONE gel 1.62% for topical use CIII Initial](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-9.jpg&id=546325)